NovoCure (NVCR) Assets Average (2015 - 2026)

NovoCure has disclosed Assets Average across 12 years of filings, most recently posting $796.1 million for Q1 2026.

• Assets Average for Q1 2026 came in at $796.1 million, down 36.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $796.1 million (down 36.04% YoY), and the FY2025 annual result was $1.0 billion, down 14.32% from the prior year.
• Assets Average came in at $796.1 million for Q1 2026 at NovoCure, down from $1.1 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.3 billion in Q3 2025 to a low of $796.1 million in Q1 2026.
• The 5-year median for Assets Average is $1.2 billion (2024), against an average of $1.2 billion.
• Across the five-year window, Assets Average increased 9.79% in 2025 and tumbled 36.04% in 2026, its largest moves.
• NovoCure's Assets Average stood at $1.2 billion in 2022, then fell by 3.1% to $1.1 billion in 2023, then grew by 7.43% to $1.2 billion in 2024, then fell by 12.07% to $1.1 billion in 2025, then decreased by 26.47% to $796.1 million in 2026.
• The last three Assets Average figures came in at $796.1 million (Q1 2026), $1.1 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.